Archive: News
-
OncLive® and The Ruesch Center Announce the Honorees of The Luminary Awards in GI Cancers
Honorees are recognized for their tremendous devotion and leadership in research, clinical care and advocacy in GI cancer.
Category: News
-
OncLive and The Ruesch Center Announce the Inaugural Luminary Awards in Gastrointestinal Cancer
The first annual Luminary Awards in GI Cancers honoring five outstanding individuals who have devoted their time, talent and resources to improving the care for patients and families affected by GI cancers, will be presented Friday, Dec. 1 at the 8th Annual Ruesch Center Symposium: Fighting a Smarter War on Cancer in Washington.
Category: News
-
Deep, Durable Responses Seen With Atezolizumab Combo For Frontline HCC Treatment
Strong efficacy signals and a tolerable safety profile were observed with the combination of atezolizumab and bevacizumab in the first-line treatment of patients with unresectable or metastatic HCC.
Category: News
-
At Cancer Bell-Ringing Ceremonies, Some Are Angry Onlookers
Bell-ringing ceremonies to mark the end of a cancer treatment are now widespread at cancer clinics around the US. For metastatic cancer patients, who cannot “beat” cancer, the sound of the bell can trigger anger, resentment, resignation, or depression.
Category: News
-
Treating GI Cancers with Proton Therapy: Ask Dr. Keith Unger
Keith Unger, MD, is a Board-certified radiation oncologist, who specializes in the use of proton therapy and other radiation treatments for gastrointestinal cancers at MedStar Georgetown University Hospital.
Category: News
-
Treating a Rare Gastrointestinal Cancer: Meeghan DeCagna’s Story
When Meeghan DeCagna was diagnosed with a rare GI cancer, called a GIST, and targeted therapy was unsuccessful, her only option was surgery to remove a six pound tumor. She found Director of Surgical Oncology at MedStar Georgetown, Waddah Al-Refaie, MD to lead her complicated operation.
Category: News
-
Current Role of Chemotherapy in GI and Colorectal Cancer
John L. Marshall, MD, discusses the use of chemotherapy in patients with colorectal (CRC) or other gastrointestinal (GI) cancers
Category: News
-
Liver Cancer Deaths Rise, Along with Hope for Better Treatments
Aiwu Ruth He, MD, PhD, an associate professor at Georgetown Lombardi Comprehensive Cancer Center, is working with colleagues on research into ways to stem rising liver cancer death rates.
Category: News
-
Advanced Pancreatic Cancer: The Road to Personalized Care
In this OncLive® Peer Exchange®, an amazing panel of experts in the field of gastrointestinal oncology provide you with a perspective on recent pancreatic cancer advances and what they mean to the care of your patients for weeks ahead.
Category: News
-
The Rising Incidence of Early-Onset CRC: What Do We Know and What Can We Do?
During an OncLive Peer Exchange® program on individualizing treatment and improving outcomes for patients with CRC, a panel of experts shared their insights on early-onset CRC, which has been observed to occur as early as adolescence.
Category: News